TENLICE-M Tablet is a powerful oral antidiabetic combination used in the management of Type 2 Diabetes Mellitus. It blends the actions of Teneligliptin, a DPP-4 (Dipeptidyl Peptidase-4) inhibitor, and Metformin, a biguanide, to provide comprehensive control over blood glucose levels.

Teneligliptin works by increasing the levels of incretin hormones, which stimulate insulin release and decrease glucagon levels in the blood, especially after meals. This helps reduce postprandial (after-meal) glucose spikes without causing hypoglycemia.

Metformin reduces the production of glucose in the liver, improves insulin sensitivity, and enhances glucose uptake by muscles, thereby lowering fasting blood sugar levels.

This combination is ideal for patients whose blood sugar is not controlled by Metformin alone. It targets both fasting and post-meal glucose levels, helping patients reach their HbA1c goals more effectively when combined with a proper diet and exercise routine.